Erectile dysfunction following surgical correction of Peyronie's disease and a pilot study of the use of sildenafil citrate rehabilitation for postoperative erectile dysfunction

被引:1
|
作者
Levine, LA [1 ]
Greenfield, JM [1 ]
Estrada, CR [1 ]
机构
[1] Rush Univ, Ctr Med, Urol Sect, Chicago, IL 60612 USA
来源
JOURNAL OF SEXUAL MEDICINE | 2005年 / 2卷 / 02期
关键词
male Peyronie's disease of Tunica albuginea; erectile dysfunction; sildenafil citrate;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Peyronie's disease (PD) is correctable by several surgical approaches including plaque incision with grafting. While the best choice of graft material remains controversial, the risk of postoperative erectile dysfunction (ED) is apparent across previous reports. Aim. We attempt to provide guidelines as to which patients may be at increased risk for developing postoperative ED after this procedure, as well as examine the role of sildenafil citrate (SC) In the postoperative period for prevention of this complication. Materials and Methods. A retrospective review was performed oil 37 patients who underwent surgical correction of PD with pericardial grafting after plaque incision. Mean follow-up was 24 months. We evaluated patient age, duration of disease, defect size, plaque location, degree of curvature, shaft narrowing, preoperative coital activity, vascular risk factors for ED, as well as preoperative erection grade and duplex ultrasound parameters. Twenty-six of these patients underwent a postoperative rehabilitation protocol of SC to enhance recovery of unassisted erections. Results. Overall, 11 patients (29%) noted diminished postoperative rigidity, that compromised unassisted coitus, compared to preoperative status. Comparison of rates of ED among those with or without vascular risk factors yielded no statistically significant results. Peyronie's disease duration, patient age, defect size, plaque location, degree of curvature, and narrowing were also insignificant predictors of which patients developed ED. An increased percentage of patients who developed ED were not sexually active preoperatively compared to those that did not develop ED (58% vs. 80%). 1,When patients were compared based on preoperative erection grade, those patients with compromised erectile function were more likely to develop postoperative ED vs. those with full erections (P < 0.05). No significant differences were found in preoperative duplex ultrasound parameters between both sets of patients. For those undergoing SC rehabilitation, 7 out of 26 (26%) developed ED in comparison to 4 out of 11 patients (36%) developing diminished rigidity when not subjected to the protocol. Conclusions. No single parameter was found that predicted the occurrence of postoperative ED with the exception of preoperative erectile status. The surgeon must carefully assess and consult each patient when considering grafting as well as consider the possible role of SC in attempting to prevent this complication.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 50 条
  • [21] Surgical Treatment of Erectile Dysfunction and Peyronie's Disease Using Malleable Prosthesis
    Yavuz, Ufuk
    Ciftci, Seyfettin
    Ustuner, Murat
    Yilmaz, Hasan
    Culha, Melih
    UROLOGY JOURNAL, 2015, 12 (06) : 2428 - 2433
  • [22] Duration of action of sildenafil citrate in men with erectile dysfunction
    Warburton, I.
    Prabhu, N. S.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 (02): : 179 - 184
  • [23] Surgical Management of Peyronie's Disease With Co-Existent Erectile Dysfunction
    Krishnappa, Pramod
    Fernandez-Pascual, Esau
    Carballido, Joaquin
    Moncada, Ignacio
    Lledo-Garcia, Enrique
    Ignacio Martinez-Salamanca, Juan
    SEXUAL MEDICINE, 2019, 7 (04): : 361 - 370
  • [24] Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis
    Xiao, Yousheng
    Wang, Jin
    Luo, Hongye
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [25] The female partner's satisfaction with sildenafil citrate treatment of erectile dysfunction
    Ichikawa, T
    Takao, A
    Manabe, D
    Saegusa, M
    Tanimoto, R
    Aramaki, K
    Yamamoto, M
    Okazaki, T
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (09) : 755 - 762
  • [26] Treatment of post APR erectile dysfunction with sildenafil - A pilot study
    Ritter, L
    Hornok, L
    Erdei, E
    8TH BIENNIAL CONGRESS OF THE EUROPEAN COUNCIL OF COLOPROCTOLOGY (ECCP), 2001, : 87 - 90
  • [27] Sildenafil citrate for Erectile Dysfunction (ED) following androgen ablation for prostate cancer
    Wang, R
    Jacobsohn, KM
    Huber, N
    JOURNAL OF ANDROLOGY, 2004, : 57 - 57
  • [29] The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction
    M Arafa
    H Eid
    A El-Badry
    K Ezz-Eldine
    R Shamloul
    International Journal of Impotence Research, 2007, 19 : 213 - 217
  • [30] Technological Advancements for Treating Erectile Dysfunction and Peyronie's Disease
    Campbell, Jeffrey D.
    Matti, Danny
    Abed, Haider
    Di Pierdominico, Andrew
    UROLOGIC CLINICS OF NORTH AMERICA, 2022, 49 (01) : 175 - 184